Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.
暂无分享,去创建一个
Vincenzo Lionetti | William C Stanley | Axel Linke | M. Chandler | F. Recchia | M. Penn | S. Gupte | T. Hintze | M. Young | A. Linke | W. Stanley | Fabio A Recchia | Margaret P Chandler | Thomas H Hintze | Marc S Penn | C. d'Agostino | Martin E Young | Sachin Gupte | Chiara d'Agostino | Vincenzo Lionetti
[1] R. Visse,et al. Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .
[2] Eric J. Topol,et al. Myeloperoxidase and Plasminogen Activator Inhibitor 1 Play a Central Role in Ventricular Remodeling after Myocardial Infarction , 2003, The Journal of experimental medicine.
[3] A. DeMaria,et al. Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.
[4] F. Recchia,et al. Preservation of NO production by statins in the treatment of heart failure. , 2003, Cardiovascular research.
[5] M. Michel,et al. Cardiac hypertrophy in the dog and rat induced by oxfenicine, an agent which modifies muscle metabolism. , 1984, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[6] A. Drake-Holland,et al. The effect of Oxfenicine on cardiac carbohydrate metabolism in intact dogs , 2005, Basic Research in Cardiology.
[7] J. Huss,et al. Nuclear receptor signaling and cardiac energetics. , 2004, Circulation research.
[8] F. Recchia,et al. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. , 1998, Circulation research.
[9] B. Chandrasekar,et al. Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase. , 2002, American journal of physiology. Heart and circulatory physiology.
[10] P. Armstrong,et al. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. , 1986, Circulation.
[11] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.
[12] O. Frazier,et al. Metabolic Gene Expression in Fetal and Failing Human Heart , 2001, Circulation.
[13] F. Spinale,et al. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. , 1998, Circulation research.
[14] M. Chandler,et al. Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. , 2004, Journal of molecular and cellular cardiology.
[15] R. Vetter,et al. Sarcoplasmic reticulum function and carnitine palmitoyltransferase‐1 inhibition during progression of heart failure , 2000, British journal of pharmacology.
[16] V. Mootha,et al. Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.
[17] D. Kelly,et al. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. , 1996, Circulation.
[18] M. Chandler,et al. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. , 2004, American journal of physiology. Heart and circulatory physiology.
[19] M. Bristow. Etomoxir: a new approach to treatment of chronic heart failure , 2000, The Lancet.
[20] William C Stanley,et al. Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-&agr; in Pacing-Induced Heart Failure , 2002, Circulation.
[21] C. Greyson,et al. Inhibition of fatty acid metabolism alters myocardial high-energy phosphates in vivo. , 1994, The American journal of physiology.
[22] Á. Zarain-Herzberg,et al. The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure , 2002, Herz.
[23] H. Taegtmeyer,et al. Reactivation of Peroxisome Proliferator-activated Receptor α Is Associated with Contractile Dysfunction in Hypertrophied Rat Heart* , 2001, The Journal of Biological Chemistry.
[24] M. Chandler,et al. Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions , 2002, Heart Failure Reviews.